SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-14-000541
Filing Date
2014-02-14
Accepted
2014-02-14 16:31:08
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D). ohr-10q_123113.htm 10-Q 740409
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 18592
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 19762
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 9169
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 9680
  Complete submission text file 0001387131-14-000541.txt   4144338

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20131231.xml EX-101.INS 759911
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20131231.xsd EX-101.SCH 20075
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20131231_cal.xml EX-101.CAL 32379
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20131231_def.xml EX-101.DEF 57260
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20131231_lab.xml EX-101.LAB 159806
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20131231_pre.xml EX-101.PRE 125554
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 14617332
SIC: 2834 Pharmaceutical Preparations